Developments in Digital Health
the document gives a monthly global overview of the key activities of companies, science and governments in Digital Health. This month the topic of Data Analytics played a major role and we invite you to actively participate through suggestions or papers for the topic of next month: Digital Health to encounter Chronic Diseases.
Have a very nice weekend and best regards,
Edition: March 2016
Health service provider activities
- The industry increasingly turns to data and analytics to address healthcare costs. As a consequence, private equity investments in health IT, originally centered on EHR systems, now focus more on systems that analyze data and a whole range of other data oriented applications.
- Tech giants are increasing collaboration with Pharma,and medtech companies.
- Pharma and insurance companies increase investment in startups.
Company activities in Pharma, Medtech, Insurance, Telecom & Consumer Health
Data analytics/Artificial intelligence:
Google’s DeepMind Technologies Ltd., an artificial intelligence company, seeks to apply its expertise to health care. The company has teamed up with the Imperial College London and the Royal Free London NHS Foundation Trust through an endeavor called DeepMind Health.
Tiatros has joined the IBM Watson Ecosystem, enabling the development by Tiatros of new cognitive computing applications to help transform chronic disease care with secure, social networks, and predictive natural language analytics.
- QIAGEN announced enhanced Clinical insight and decision support system in oncology labs
- Molecular Health expands its Engineus™ platform to healthcare decision support products in oncology domain
HealthHelp offers a clinical decision support system that allows providers to self-govern the ordering process and receive approval for decisions
- UnitedHealth & Qualcomm are set to launch "United Health motion" program
- Philips unveiled 24/7 mobile medical alert service Philips lifeline "GoSafe"
- Novartis signed deals with Cigna and Aetna for heart failure drug "Entresto"
- Philips Respironics receives FDA501(k) Clearance to its clinical management solution
- Philips and Monica Healthcare collabote on "fetal monitoring solution"
- Novartis and Qualcomm life to develop connected inhaler for COPD patients
Health service provider activities
The free SleepHealth app, developed by the American Sleep Apnea Association (ASAA) and IBM, is part of the first ResearchKit study to run on IBM's Watson Health Cloud. It will collect data on sleep quality and daytime activities, health and medical conditions and productivity and alertness.
A team of physicians and analysts at Memorial Sloan Kettering has been “training” IBM Watson for more than a year to develop a tool that can help medical professionals choose the best treatment plans for individual cancer patients.
Manipal Hospitals' corporate and teaching facilities will adopt Watson for Oncology
- IBM announced to buy Truven Health Analytics, a provider of cloud-based health care data, for $2.6 billion, the company’s fourth major health-related acquisition since launching the Watson Health unit in April 2015
- Roche invested $175 million in Genome sequencing Big data firm Foundation medicine
- Qualcomm and GSK launch Medical device Joint venture worth $1 Billion
- AXA Strategic Ventures (ASV) invests in Medlanes Berlin (Est.amount €3 million)
- MaaT Pharma receives €10 million series A funding for clinical trails support.
- Medgenome receives $20 Million series B funding from Sequoia Capital
- Philips, EDBI singapore to create a new venture arm (SGD 50 million)
- Tencent invests $90 Million series C funding in Practo
- ASICS has acquired Fitnesskeeper for $85 million
- EU working group aims to draft guidelines to improve mHealth apps data quality
- Collecting European digital health data by Non-EU companies will be illegal ( EU-GDPR)
EU GDPR drafts policy to regulate the sharing of health data from wearable medical devices
US FDA is set to propose to new guidelines in April for access of EHR
Recent grant opportunities in Europe and globally:
EU Horizon announces new programms for SMEs in 2016 and 2017: http://ec.europa.eu/research/participants/data/ref/h2020/wp/2016_2017/main/h2020-wp1617-sme_en.pdf
German BMBF announced crossboarder projects, e.g. Brazil collaborations: http://www.fapesp.br/en/9398
This month topic: Data analytics in Oncology
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer: The review adresses the challenge of personalized oncology considering the complexity of tumor heterogeneity, clinical outcome,and treatment toxicity. It analyzes the current possibilities of data-mining processes and machine-learning approaches and introduces the concept of an umbrella protocol. http://www.ncbi.nlm.nih.gov/pubmed/26674745
Translating Cancer Genomes and Transcriptomes for Precision Oncology: This paper bases on the comprehensive view of an individual patient’s cancer the genome and transcriptome together can provide.The authors discuss several opportunities for translating this basic science knowledge into clinical practice, including a molecular classification of cancer, heritable risk of cancer, eligibility for targeted therapies, and the development of innovative, genomic-based clinical trials. Especially the summary points in table 2 gives a comprehensive overview of the challenges for Data analytics, especially semantic technologies, from the perspective of an oncologist. It makes obvious, that translating the cancer genome and transcriptome for patients will require continued multidisciplinary collaboration between oncologists, pathologists, basic scientists, and computational biologists. http://www.ncbi.nlm.nih.gov/pubmed/26528881
- The Future of Molecular Medicine : Biomarkers, BATTLEs, and Big Data: The good structured article shows, that innovative practice of medicine requires, besides other new techniques, also molecular testing and utilization of information obtained from big data. Very helpful is the overview on selected umbrella and Master Trials. http://www.ncbi.nlm.nih.gov/pubmed/25993137
- Open Access to Large Scale Datasets Is Needed to Translate Knowledge of Cancer Heterogeneity into Better Patient Outcomes: The author of this short article shows with concrete examples, what kind of IT infrastructure is needed to enable sharing of the Omics and clinical data with a large community of cancer researchers and data scientists. http://www.ncbi.nlm.nih.gov/pubmed/25710538
Key events (Expert Meetings, Conferences and Summits):
March 30, 9am EST, Webinar: The Global Demand for Tele-Pediatric Care (https://www.avizia.com/webinar-the-global-demand-for-tele-pediatric-care/)
Mar 31, 6:00 PM - 7:00 PM CEST, Webinar: Telehealth experience with maternal fetal medicine (https://attendee.gotowebinar.com/register/7255485188877227777)
April 5: Syte Digital Health Summit Lisbon
April 6-8: Med-e-Tel Luxembourg. An event of the International Society for Telemedicine & eHealth (ISfTeH), It is the international federation of national associations who represent their country’s Telemedicine and eHealth stakeholders (https://www.medetel.eu/index.php)
April 6-8: Telemedicine Programs & Services, Maitland, USA (http://www.wplgroup.com/aci/event/telemedicine-programs-and-services/)
April 24-25: ICT4AWE, Rome, Italy (http://www.ict4ageingwell.org )
April 24-28: eTelemed 2016, Venice, Italy (http://www.iaria.org/conferences2016/eTELEMED16.html)
6th International conference on Digital Health Montreal 11-13 April
April 28: Syte Digital Health Conference Singapore at NUS
May 5: MM&M Transforming Healthcare Conference in New York
May 8-11: Health Datapalooza in Washington
May 10-12: Health 2.0 Europe 2016 in Barcelona
May 14-17: ATA 2016 in Minneapolis
May 17-20: Four Day Syte Digital Health Conference at Hospitalar in Sao Paulo
The content of this newsletter was researched through the Syte team from different resources including academic publications, specific and general reports, online publications and proprietary sources.
Syte publishes this newsletter only for targeted subscribers. We do not intend to enter into contracts with any organizations. The country of origin and place of jurisdiction is Germany.
The newsletter contains information about Digital Health. The information is not advice, and should not be treated as such.
Without prejudice to the generality of the foregoing paragraph, we do not represent, warrant, undertake or guarantee that the information in the newsletter is correct, accurate, complete or non-misleading.
The linked sites are not part of the newsletter. The original author owns the intellectual property rights to the material on the linked sites.
Syte will not be liable to you in respect of any special, indirect or consequential loss or damage.